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CASE REPORT
Severe Local Toxicity after Lung Stereotactic Body
Radiation Therapy
Lesional Abscess Leading to Bronchocutaneous Fistula Requiring
Surgical Marsupialization
Neil M. Woody, BS,* Toufik Djemil, PhD,* David J. Adelstein, MD,† David P. Mason, MD,‡
Thomas W. Rice, MD,‡ and Gregory M. M. Videtic, MD*
Stereotactic body radiation therapy (SBRT) is increasinglyused for managing medically inoperable early stage lung
cancer or oligometastatic lung lesions.1,2 Characterized by
excellent local tumor control and low toxicity rates, SBRT
has been associated with chest wall (CW) and skin toxicities
developing months to years after treatment and manifesting
as self-limited pain,3 fracture, or dermatitis. Rarely, these
toxicities include soft tissue necrosis.4 We describe a case of
severe post-SBRT necrosis at the treated site, resulting in an
abscess and a cutaneous fistula ultimately requiring surgical
debridement.
CASE
In October 2008, a 49-year-old man judged to be
medically inoperable was referred for lung SBRT to a biopsy-
proven recurrence of squamous cell carcinoma (SCC) of the
left lower lobe (LLL). His oncologic history, starting in
2004,revealed serial SCCs of the right anterior tongue, left
tonsil, and left pyriform sinus. In June 2008, he underwent
lobectomy/lymphadenectomy for a presumed new primary
1.2-cm pleural based SCC of the LLL. LLL relapse with
worsening postthoracotomy CW pain prompted his current
presentation.
SBRT to the LLL lesion using positron emission to-
mography for target volume delineation consisted of 50 Gy/5
fractions/5 consecutive days, using seven-beam noncoplanar
intensity modulated radiotherapy prescribed to the 93.5%
isodose line. Figure 1 shows representative planning com-
puted tomography images. The patient tolerated SBRT with-
out complications. Three months after SBRT, he reported
some reduction in CW pain in the treated field, although he
still required narcotics. Imaging at 6 months revealed evolv-
ing LLL response but new lung nodules, prompting four
cycles of carboplatin/paclitaxel. In January 2010, a persistent
right upper lobe nodule was treated with SBRT, 50 Gy/5
fractions, without complications. Ongoing left CW pain led to
local nerve blocks, with incomplete pain resolution.
Seventeen months after SBRT to the LLL, the patient
was well, but computed tomography imaging revealed air
within the treated LLL, concerning for necrosis with ab-
scess (Figure 2A). Despite oral antibiotics, the patient
became febrile, and blood cultures were positive for me-
thicillin-resistant Staphylococcus aureus. Conservative
management was chosen, and intravenous vancomycin was
started. Five weeks later, pus spontaneously erupted from the
left posterior CW. The patient underwent excision of an
abscess cavity and bronchocutaneous fistula followed by
marsupialization (Figure 2B). Surgical pathology revealed no
evidence of malignancy.
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FIGURE 1. A representative planning axial computed tomog-
raphy chest image showing the gross tumor volume and plan-
ning target volume in brown and orange, respectively. Red,
green, and blue lines show the volume receiving 50, 30, and
10 Gy of total dose, respectively.
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DISCUSSION
To our knowledge, this is the first report of post-SBRT
lung necrosis with abscess and fistulation. We retrospectively
reanalyzed the patient’s plan and found that the volume of
CW exceeding 30 Gy was 66 ml, and maximum skin dose
was 34 Gy. In our SBRT experience, restricting V30 to 35
ml was associated with15% risk of CW toxicity.5 Hoppe et
al.4 reported an association between grade 2 skin toxicity
and the use of only three beams for SBRT, and a tumor
distance to the posterior CW skin 5 cm and a maximum
skin dose of 50% or higher of the prescribed dose. Although
this patient’s values exceeded the above recommendations,
neither was extreme, and none of our patients with equal or
greater V30 had similar toxicity, suggesting an isolated albeit
severe event.
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FIGURE 2. A, Representative axial com-
puted tomography (CT) chest image with-
out contrast at 17 months post-stereotactic
body radiation therapy (SBRT). Arrow indi-
cates air in lesion suggesting abscess. B,
Representative axial CT chest image without
contrast at 19 months post-SBRT. Arrow
indicates abscess cavity after resection and
marsupialization.
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